Published online Apr 26, 2023. doi: 10.12998/wjcc.v11.i12.2670
Peer-review started: January 29, 2023
First decision: February 17, 2023
Revised: March 10, 2023
Accepted: March 27, 2023
Article in press: March 27, 2023
Published online: April 26, 2023
Processing time: 86 Days and 1.2 Hours
For thousands of years, medicinal cannabis has been used for pain treatment, but its use for pain management is still controversial. Meta-analysis of the literature has shown contrasting results on the addition of cannabinoids to opioids compared with placebo/other active agents to reduce pain. Clinical studies are mainly focused on medicinal cannabis use in chronic pain management, for which the analgesic effect has been proven in many studies. This review focuses on the potential use of medical cannabis for acute pain management in preclinical studies, studies on healthy subjects and the few pioneering studies in the clinical setting.
Core Tip: Medicinal cannabis use for pain management is still controversial. Meta-analysis of the literature has shown contrasting results on the addition of cannabinoids to opioids to in reducing pain. Clinical studies are mainly focused on medicinal cannabis use in chronic pain management, for which the analgesic effect has been proven in many studies. This present review focuses on the potential application of medical cannabis for acute pain, exploring the physiopathology of the endocannabinoid system, preclinical studies, studies on healthy subjects and the few pioneering studies in the clinical setting.
